Welven Ltd v Soar Group Ltd & Anor [2011] EWHC 3240 (Comm) (09 December 2011)

Welven Ltd v Soar Group Ltd & Anor [2011] EWHC 3240 (Comm) (09 December 2011)

The Defendants failed to prove any actionable misrepresentation (fraudulent, negligent, or innocent) by Welven inducing entry into the SPA. The evidence showed the Defendants were provided with all relevant financial information, including the limitations of stock estimates and management accounts. The SPA's warranties were not breached, and the Defendants' counterclaims for damages and breach of warranty were struck out by prior court orders. The only live issue was set-off for price adjustment, which is limited to the Mazars determination. Welven is entitled to the balance of deferred consideration, less the agreed set-off.

Citation
[2011] EWHC 3240 (Comm)
Parties
Claimant: Welven Limited; First Defendant: Soar Group Limited; Second Defendant: Barry James Aughey
Jurisdiction
England and Wales
Judgment Date
09 December 2011
Procedural Posture
Commercial Contract Claim / High Court Trial Judgment
Outcome
Claim allowed (subject to set-off); Defendants' defences and counterclaims dismissed
Legal Topics
Share Sale Agreement, Misrepresentation, Breach of Warranty, Set Off, Guarantee, Damages, Disclosure, Procedural Orders

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 4 Authorities cited 3 Party arguments 2 Amounts and remedies 4
Sign in to unlock

Parties

Welven Limited

Claimant

Soar Group Limited

First Defendant

Barry James Aughey

Second Defendant

Procedural Posture

Commercial Contract Claim / High Court Trial Judgment

  1. 1 Whether the Defendants were induced to enter the SPA by fraudulent, negligent, or innocent misrepresentation
  2. 2 Whether the Claimant is entitled to the balance of deferred consideration under the SPA
  3. 3 Whether the Defendants are entitled to set off any losses against the deferred consideration

Ratio Decidendi

The Defendants failed to prove any actionable misrepresentation (fraudulent, negligent, or innocent) by Welven inducing entry into the SPA. The evidence showed the Defendants were provided with all relevant financial information, including the limitations of stock estimates and management accounts. The SPA's warranties were not breached, and the Defendants' counterclaims for damages and breach of warranty were struck out by prior court orders. The only live issue was set-off for price adjustment, which is limited to the Mazars determination. Welven is entitled to the balance of deferred consideration, less the agreed set-off.

Court Disposition

Claim allowed (subject to set-off); Defendants' defences and counterclaims dismissed

Orders

  • Defendants to pay Welven Limited the balance of £1.25 million deferred consideration under the SPA, less the net set-off determined by Mazars and any further agreed set-off.
  • Interest payable as per SPA terms.